MedTrace Logo

InterFuse® S and T for the Treatment of Scoliosis, Spondylolisthesis and Degenerative Disc Disease (DDD)

NCT02659722 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2016-11-02

No results posted yet for this study

Summary

The primary objective of this prospective, post-market study is to collect data to assess the long term outcome of a broad contact modular interbody device in the form of the InterFuse S™ or InterFuse T™ device in patients undergoing long construct fusion for degenerative disc disease and/or scoliosis. Comparisons will be made with published historical data..

Conditions

Interventions

DEVICE

InterFuse

TRansforaminal or Posterior placement of an InterFuse S and/or T device, in combination with approved posterior fixation

Sponsors & Collaborators

  • Vertebral Technologies, Inc.

    lead INDUSTRY

Principal Investigators

  • William Lavelle, MD · SUNY Unpstate

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2018-06-30
Completion
2019-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02659722 on ClinicalTrials.gov